CA Stock MarketDetailed Quotes

AbbVie CDR (CAD Hedged) (ABBV)

Watchlist
  • 29.240
  • -0.050-0.17%
15min DelayMarket Closed Apr 17 16:00 ET
488.68BMarket Cap85.25P/E (TTM)

AbbVie CDR (CAD Hedged) (ABBV) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
8.57%61.16B
10.04%16.62B
9.10%15.78B
6.65%15.42B
8.39%13.34B
3.71%56.33B
5.60%15.1B
3.83%14.46B
4.31%14.46B
0.70%12.31B
Operating revenue
8.57%61.16B
10.04%16.62B
9.10%15.78B
6.65%15.42B
8.39%13.34B
3.71%56.33B
5.60%15.1B
3.83%14.46B
4.31%14.46B
0.70%12.31B
Cost of revenue
7.69%18.2B
3.55%4.55B
25.93%5.3B
3.43%4.35B
-2.25%4B
-17.20%16.9B
-22.93%4.4B
-35.05%4.21B
-0.90%4.2B
2.71%4.09B
Gross profit
8.94%42.96B
12.70%12.07B
2.19%10.47B
7.96%11.08B
13.69%9.34B
16.30%39.43B
24.53%10.71B
37.70%10.25B
6.60%10.26B
-0.28%8.22B
Operating expense
-16.96%22.87B
-41.09%6.26B
-7.06%5.89B
0.66%5.36B
2.02%5.36B
35.19%27.54B
107.46%10.62B
24.34%6.34B
10.20%5.33B
-1.26%5.25B
Selling and administrative expenses
-5.03%14.01B
1.04%3.9B
-15.12%3.57B
-3.67%3.25B
-0.66%3.29B
14.61%14.75B
20.73%3.86B
24.70%4.21B
3.34%3.38B
9.08%3.32B
Research and development costs
-28.89%9.1B
-61.93%2.58B
8.87%2.32B
9.39%2.13B
6.60%2.07B
66.66%12.79B
251.53%6.77B
23.62%2.13B
12.41%1.95B
-15.40%1.94B
Other operating expenses
-3,342.86%-241M
---217M
----
---24M
----
96.09%-7M
----
----
----
----
Operating profit
68.92%20.09B
6,815.48%5.81B
17.15%4.58B
15.85%5.72B
34.40%3.98B
-12.12%11.89B
-97.58%84M
66.72%3.91B
2.96%4.94B
1.51%2.96B
Net non-operating interest income (expenses)
-21.62%-2.63B
-7.38%-655M
-12.86%-667M
-33.99%-678M
-38.41%-627M
-28.27%-2.16B
-61.38%-610M
-48.49%-591M
-11.45%-506M
0.22%-453M
Non-operating interest income
-58.95%266M
-35.87%59M
-44.19%72M
-71.82%62M
-64.73%73M
20.00%648M
-50.54%92M
-17.83%129M
124.49%220M
109.09%207M
Non-operating interest expense
3.03%2.89B
1.71%714M
2.64%739M
1.93%740M
6.06%700M
26.26%2.81B
24.47%702M
29.73%720M
31.52%726M
19.35%660M
Other net income (expenses)
-80.57%-10.87B
-42.63%-2.49B
-158.72%-3.2B
-52.65%-3.49B
-124.54%-1.69B
-7.45%-6.02B
7.63%-1.74B
-31,050.00%-1.24B
-32.04%-2.28B
62.09%-754M
Gain on sale of security
-176.19%-58M
42.11%-11M
-766.67%-20M
-2,200.00%-23M
0.00%-4M
85.62%-21M
61.22%-19M
112.00%3M
97.30%-1M
88.57%-4M
Special income (charges)
-81.94%-5.02B
19.63%-1.27B
-3,168.29%-2.68B
12.17%-823M
-51.22%-248M
-254.37%-2.76B
-458.16%-1.57B
-24.24%-82M
-234.64%-937M
-9.33%-164M
-Less:Other special charges
81.94%5.02B
-19.63%1.27B
3,168.29%2.68B
-12.17%823M
51.22%248M
254.37%2.76B
458.16%1.57B
24.24%82M
234.64%937M
9.33%164M
Other non-operating income (expenses)
-78.80%-5.79B
-706.67%-1.21B
56.60%-503M
-96.21%-2.64B
-145.90%-1.44B
30.72%-3.24B
90.36%-150M
-1,320.00%-1.16B
4.75%-1.35B
67.52%-586M
Income before tax
77.53%6.6B
217.58%2.67B
-65.74%714M
-27.59%1.55B
-5.36%1.66B
-40.54%3.72B
-287.21%-2.27B
6.71%2.08B
-17.78%2.15B
269.47%1.76B
Income tax
514.74%2.36B
137.98%853M
1.15%526M
-20.70%613M
-2.87%372M
-141.39%-570M
-678.87%-2.25B
202.33%520M
32.59%773M
63.68%383M
Earnings from equity interest net of tax
Net income
-1.24%4.23B
7,991.30%1.82B
-87.98%188M
-31.46%941M
-6.05%1.29B
-12.05%4.29B
-102.79%-23M
-12.18%1.56B
-32.26%1.37B
469.29%1.37B
Net income continuous operations
-1.24%4.23B
7,991.30%1.82B
-87.98%188M
-31.46%941M
-6.05%1.29B
-12.05%4.29B
-102.79%-23M
-12.18%1.56B
-32.26%1.37B
469.29%1.37B
Noncontrolling interests
-12.50%7M
0.00%-1M
-33.33%2M
0.00%3M
0.00%3M
-20.00%8M
-150.00%-1M
0.00%3M
0.00%3M
50.00%3M
Net income attributable to the company
-1.22%4.23B
8,354.55%1.82B
-88.08%186M
-31.53%938M
-6.06%1.29B
-12.03%4.28B
-102.68%-22M
-12.20%1.56B
-32.31%1.37B
472.80%1.37B
Preferred stock dividends
Other under preferred stock dividend
0.00%40M
0.00%10M
0.00%10M
0.00%10M
0.00%10M
-6.98%40M
-9.09%10M
-9.09%10M
-9.09%10M
-9.09%10M
Net income attributable to common stockholders
-1.23%4.19B
5,743.75%1.81B
-88.65%176M
-31.76%928M
-6.11%1.28B
-12.07%4.24B
-103.95%-32M
-12.22%1.55B
-32.44%1.36B
496.05%1.36B
Diluted earnings per share
-1.25%0.2508
8,342.08%0.1087
-88.64%0.0106
-32.47%0.055
-6.49%0.0762
-12.09%0.254
-102.68%-0.0013
-12.00%0.0931
-32.46%0.0815
492.32%0.0815
Basic earnings per share
-0.84%0.2508
5,199.15%0.1079
-88.64%0.0106
-32.47%0.055
-6.49%0.0762
-12.13%0.2529
-104.35%-0.0021
-12.00%0.0931
-32.46%0.0815
492.32%0.0815
Dividend per share
0.92%0.6672
0.83%0.1651
4.01%0.1697
3.94%0.1707
-4.88%0.1617
2.16%0.6611
3.49%0.1637
-2.57%0.1632
2.71%0.1642
5.21%0.1701
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 8.57%61.16B10.04%16.62B9.10%15.78B6.65%15.42B8.39%13.34B3.71%56.33B5.60%15.1B3.83%14.46B4.31%14.46B0.70%12.31B
Operating revenue 8.57%61.16B10.04%16.62B9.10%15.78B6.65%15.42B8.39%13.34B3.71%56.33B5.60%15.1B3.83%14.46B4.31%14.46B0.70%12.31B
Cost of revenue 7.69%18.2B3.55%4.55B25.93%5.3B3.43%4.35B-2.25%4B-17.20%16.9B-22.93%4.4B-35.05%4.21B-0.90%4.2B2.71%4.09B
Gross profit 8.94%42.96B12.70%12.07B2.19%10.47B7.96%11.08B13.69%9.34B16.30%39.43B24.53%10.71B37.70%10.25B6.60%10.26B-0.28%8.22B
Operating expense -16.96%22.87B-41.09%6.26B-7.06%5.89B0.66%5.36B2.02%5.36B35.19%27.54B107.46%10.62B24.34%6.34B10.20%5.33B-1.26%5.25B
Selling and administrative expenses -5.03%14.01B1.04%3.9B-15.12%3.57B-3.67%3.25B-0.66%3.29B14.61%14.75B20.73%3.86B24.70%4.21B3.34%3.38B9.08%3.32B
Research and development costs -28.89%9.1B-61.93%2.58B8.87%2.32B9.39%2.13B6.60%2.07B66.66%12.79B251.53%6.77B23.62%2.13B12.41%1.95B-15.40%1.94B
Other operating expenses -3,342.86%-241M---217M-------24M----96.09%-7M----------------
Operating profit 68.92%20.09B6,815.48%5.81B17.15%4.58B15.85%5.72B34.40%3.98B-12.12%11.89B-97.58%84M66.72%3.91B2.96%4.94B1.51%2.96B
Net non-operating interest income (expenses) -21.62%-2.63B-7.38%-655M-12.86%-667M-33.99%-678M-38.41%-627M-28.27%-2.16B-61.38%-610M-48.49%-591M-11.45%-506M0.22%-453M
Non-operating interest income -58.95%266M-35.87%59M-44.19%72M-71.82%62M-64.73%73M20.00%648M-50.54%92M-17.83%129M124.49%220M109.09%207M
Non-operating interest expense 3.03%2.89B1.71%714M2.64%739M1.93%740M6.06%700M26.26%2.81B24.47%702M29.73%720M31.52%726M19.35%660M
Other net income (expenses) -80.57%-10.87B-42.63%-2.49B-158.72%-3.2B-52.65%-3.49B-124.54%-1.69B-7.45%-6.02B7.63%-1.74B-31,050.00%-1.24B-32.04%-2.28B62.09%-754M
Gain on sale of security -176.19%-58M42.11%-11M-766.67%-20M-2,200.00%-23M0.00%-4M85.62%-21M61.22%-19M112.00%3M97.30%-1M88.57%-4M
Special income (charges) -81.94%-5.02B19.63%-1.27B-3,168.29%-2.68B12.17%-823M-51.22%-248M-254.37%-2.76B-458.16%-1.57B-24.24%-82M-234.64%-937M-9.33%-164M
-Less:Other special charges 81.94%5.02B-19.63%1.27B3,168.29%2.68B-12.17%823M51.22%248M254.37%2.76B458.16%1.57B24.24%82M234.64%937M9.33%164M
Other non-operating income (expenses) -78.80%-5.79B-706.67%-1.21B56.60%-503M-96.21%-2.64B-145.90%-1.44B30.72%-3.24B90.36%-150M-1,320.00%-1.16B4.75%-1.35B67.52%-586M
Income before tax 77.53%6.6B217.58%2.67B-65.74%714M-27.59%1.55B-5.36%1.66B-40.54%3.72B-287.21%-2.27B6.71%2.08B-17.78%2.15B269.47%1.76B
Income tax 514.74%2.36B137.98%853M1.15%526M-20.70%613M-2.87%372M-141.39%-570M-678.87%-2.25B202.33%520M32.59%773M63.68%383M
Earnings from equity interest net of tax
Net income -1.24%4.23B7,991.30%1.82B-87.98%188M-31.46%941M-6.05%1.29B-12.05%4.29B-102.79%-23M-12.18%1.56B-32.26%1.37B469.29%1.37B
Net income continuous operations -1.24%4.23B7,991.30%1.82B-87.98%188M-31.46%941M-6.05%1.29B-12.05%4.29B-102.79%-23M-12.18%1.56B-32.26%1.37B469.29%1.37B
Noncontrolling interests -12.50%7M0.00%-1M-33.33%2M0.00%3M0.00%3M-20.00%8M-150.00%-1M0.00%3M0.00%3M50.00%3M
Net income attributable to the company -1.22%4.23B8,354.55%1.82B-88.08%186M-31.53%938M-6.06%1.29B-12.03%4.28B-102.68%-22M-12.20%1.56B-32.31%1.37B472.80%1.37B
Preferred stock dividends
Other under preferred stock dividend 0.00%40M0.00%10M0.00%10M0.00%10M0.00%10M-6.98%40M-9.09%10M-9.09%10M-9.09%10M-9.09%10M
Net income attributable to common stockholders -1.23%4.19B5,743.75%1.81B-88.65%176M-31.76%928M-6.11%1.28B-12.07%4.24B-103.95%-32M-12.22%1.55B-32.44%1.36B496.05%1.36B
Diluted earnings per share -1.25%0.25088,342.08%0.1087-88.64%0.0106-32.47%0.055-6.49%0.0762-12.09%0.254-102.68%-0.0013-12.00%0.0931-32.46%0.0815492.32%0.0815
Basic earnings per share -0.84%0.25085,199.15%0.1079-88.64%0.0106-32.47%0.055-6.49%0.0762-12.13%0.2529-104.35%-0.0021-12.00%0.0931-32.46%0.0815492.32%0.0815
Dividend per share 0.92%0.66720.83%0.16514.01%0.16973.94%0.1707-4.88%0.16172.16%0.66113.49%0.1637-2.57%0.16322.71%0.16425.21%0.1701
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More